SENSEX NIFTY

Chemo Pharma La

Jan 20, 2015 at 22:23 | Source: Moneycontrol.com
Chemo Pharma Laboratories at its Meeting held on January 20, 2015, inter-alia, took the decisions. The Board appointed M/s. S. K. Jain & Co., Practicing Company Secretaries as Secretarial Auditor of the Company as per Section 204 of the Companies Act, 2013.
Jan 07, 2015 at 13:14 | Source: Moneycontrol.com
Chemo Pharma Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 20, 2015, to Consider and Approve the Un-audited Financial Results for the quarter ended December 31, 2014.
Oct 22, 2014 at 19:05 | Source: Moneycontrol.com
Chemo-Pharma Laboratories has reported a sales total income from operations of Rs 0.11 crore and a net profit of Rs 0.07 crore for the quarter ended Sep '14
Sep 29, 2014 at 13:07 | Source: Moneycontrol.com
Chemo Pharma Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 26, 2014, approved the Resignation of Shri Ashok Joshi from the position of Compliance Officer, Chief Financial Officer and Directorship of the Company.
Sep 15, 2014 at 15:08 | Source: Moneycontrol.com
Chemo Pharma Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on September 26, 2014, to consider and approve the Resignation of Shri. Ashok Joshi from the position of Compliance Officer, Chief Financial Officer and Directorship of the Company
Aug 20, 2014 at 11:29 | Source: Moneycontrol.com
GBR 1302 was discovered and developed by Glenmark Biologics Research Centre located in La Chaux-de-Fonds, Switzerland and would be first molecule to could become a patented molecule or drug for the company once it goes through multiple stages of research and development.
Aug 20, 2014 at 10:30 | Source: CNBC-TV18
GBR 1302 was discovered and developed by Glenmark Biologics Research Centre located in La Chaux-de-Fonds, Switzerland and would be first molecule to could become a patented molecule or drug for the company once it goes through multiple stages of research and development.
Jul 18, 2014 at 15:56 | Source: Moneycontrol.com
Chemo-Pharma Laboratories has reported a sales standalone turnover of Rs 0.11 crore and a net profit of Rs 0.10 crore for the quarter ended Jun '14
Jun 04, 2014 at 15:57 | Source: PTI
Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of the company has opened its new cGMP compliant monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland.
May 26, 2014 at 13:46 | Source: Moneycontrol.com
Chemo-Pharma Laboratories has reported a sales standalone turnover of Rs 0.24 crore and a net profit of Rs 0.17 crore for the quarter ended Mar '14